[HTML][HTML] Everything old is new again: drug repurposing approach for non-small cell lung cancer targeting MAPK signaling pathway
Non-small cell lung cancer (NSCLC) is a prominent subtype of lung carcinoma that accounts
for the majority of cancer-related deaths globally, and it is responsible for about 80% to 85 …
for the majority of cancer-related deaths globally, and it is responsible for about 80% to 85 …
[HTML][HTML] Insights into fourth generation selective inhibitors of (C797S) EGFR mutation combating non-small cell lung cancer resistance: a critical review
Lung cancer is the second most common cause of morbidity and mortality among cancer
types worldwide, with non-small cell lung cancer (NSCLC) representing the majority of most …
types worldwide, with non-small cell lung cancer (NSCLC) representing the majority of most …
Baicalein: A review on its anti‐cancer effects and mechanisms in lung carcinoma
N Chandrashekar, A Pandi - Journal of Food Biochemistry, 2022 - Wiley Online Library
Plant‐derived flavonoids are reported to function as potential anti‐cancer agents against
different types of cancer. Baicalein (BE) is an important flavonoid found in the roots of …
different types of cancer. Baicalein (BE) is an important flavonoid found in the roots of …
[HTML][HTML] The role of selected non-coding RNAs in the biology of non-small cell lung cancer
K Kiełbowski, K Ptaszyński, J Wojcik… - Advances in Medical …, 2023 - Elsevier
Lung cancer is the second most frequently diagnosed cancer worldwide and a leading
cause of cancer-related deaths. Non-small cell lung carcinoma (NSCLC) represents 85% of …
cause of cancer-related deaths. Non-small cell lung carcinoma (NSCLC) represents 85% of …
[HTML][HTML] Leptomeningeal metastasis: a review of the pathophysiology, diagnostic methodology, and therapeutic landscape
A Nguyen, A Nguyen, OT Dada, PD Desai, JC Ricci… - Current …, 2023 - mdpi.com
The present review aimed to establish an understanding of the pathophysiology of
leptomeningeal disease as it relates to late-stage development among different cancer …
leptomeningeal disease as it relates to late-stage development among different cancer …
[HTML][HTML] Clinical presentation and outcome of patients with enteric-type adenocarcinoma of the lung: a pooled analysis of published cases
E Fassi, M Mandruzzato, M Zamparini, S Bianchi… - Lung Cancer, 2023 - Elsevier
Enteric-type adenocarcinoma of the lung (lung-ETAC, former pulmonary enteric
adenocarcinoma, PEAC) is a rare subtype of non-small cell lung cancer (NSCLC), which …
adenocarcinoma, PEAC) is a rare subtype of non-small cell lung cancer (NSCLC), which …
Isoliquiritigenin inhibits non-small cell lung cancer progression via m6A/IGF2BP3-dependent TWIST1 mRNA stabilization
Y Cui, Y Wu, C Wang, Z Wang, Y Li, Z Jiang, W Zhao… - Phytomedicine, 2022 - Elsevier
Abstract Background N 6-methyladenosine (m 6 A) has been identified to regulate the
tumorigenesis and development of various tumors, including non-small cell lung cancer …
tumorigenesis and development of various tumors, including non-small cell lung cancer …
[HTML][HTML] HDAC inhibitor ITF2357 reduces resistance of mutant-KRAS non-small cell lung cancer to pemetrexed through a HDAC2/miR-130a-3p-dependent …
J Cui, F Xu, W Bai, T Zhao, J Hong, W Zuo - Journal of Translational …, 2023 - Springer
Background Histone deacetylases (HDAC) contribute to oncogenic program, pointing to
their inhibitors as a potential strategy against cancers. We, thus, studied the mechanism of …
their inhibitors as a potential strategy against cancers. We, thus, studied the mechanism of …
[HTML][HTML] Activities against lung cancer of biosynthesized silver nanoparticles: a review
JL Mejía-Méndez, ER López-Mena, E Sánchez-Arreola - Biomedicines, 2023 - mdpi.com
Nanomedicine is an interdisciplinary field where nanostructured objects are applied to treat
or diagnose disease. Nanoparticles (NPs) are a special class of materials at nanometric …
or diagnose disease. Nanoparticles (NPs) are a special class of materials at nanometric …
Chlorin e6-induced photodynamic effect facilitates immunogenic cell death of lung cancer as a result of oxidative endoplasmic reticulum stress and DNA damage
TT Yu, J Hu, QR Li, XC Peng, HZ Xu, N Han… - International …, 2023 - Elsevier
Suppression of the immune microenvironment is an important endogenous contributor to
treatment failure in lung cancer. Photodynamic therapy (PDT) is widely used in the treatment …
treatment failure in lung cancer. Photodynamic therapy (PDT) is widely used in the treatment …